Fidelity Investments’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270M | Sell |
5,730,549
-596,465
| -9% | -$28.2M | 0.02% | 705 |
|
|
2025
Q1 | $247M | Sell |
6,327,014
-14,377
| -0.2% | -$562K | 0.02% | 719 |
|
|
2024
Q4 | $343M | Buy |
6,341,391
+1,391,167
| +28% | +$75.3M | 0.02% | 603 |
|
|
2024
Q3 | $250M | Buy |
4,950,224
+1,306,215
| +36% | +$65.9M | 0.02% | 749 |
|
|
2024
Q2 | $160M | Sell |
3,644,009
-726,643
| -17% | -$32M | 0.01% | 865 |
|
|
2024
Q1 | $220M | Buy |
4,370,652
+522,974
| +14% | +$26.3M | 0.01% | 753 |
|
|
2023
Q4 | $232M | Buy |
3,847,678
+450,425
| +13% | +$27.2M | 0.02% | 690 |
|
|
2023
Q3 | $194M | Buy |
3,397,253
+19,508
| +0.6% | +$1.11M | 0.02% | 713 |
|
|
2023
Q2 | $172M | Buy |
3,377,745
+2,902,313
| +610% | +$148M | 0.01% | 775 |
|
|
2023
Q1 | $10.2M | Buy |
475,432
+289,932
| +156% | +$6.2M | ﹤0.01% | 1869 |
|
|
2022
Q4 | $1.95M | Sell |
185,500
-633,677
| -77% | -$6.65M | ﹤0.01% | 2378 |
|
|
2022
Q3 | $6.52M | Sell |
819,177
-374,113
| -31% | -$2.98M | ﹤0.01% | 2077 |
|
|
2022
Q2 | $6.26M | Buy |
1,193,290
+290
| +0% | +$1.52K | ﹤0.01% | 2162 |
|
|
2022
Q1 | $13.2M | Hold |
1,193,000
| – | – | ﹤0.01% | 2003 |
|
|
2021
Q4 | $11.8M | Buy |
+1,193,000
| New | +$11.8M | ﹤0.01% | 2049 |
|